These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1750596)

  • 21. Malignant hyperthermia: a review of the literature.
    Rodgers IR
    Mt Sinai J Med; 1983; 50(1):95-8. PubMed ID: 6341821
    [No Abstract]   [Full Text] [Related]  

  • 22. [Malignant hyperthermia].
    Bouhajja B; Haddad F; Ben Ammar MS
    Tunis Med; 2002 Jul; 80(7):395-401. PubMed ID: 12611349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and management of susceptibility to malignant hyperthermia in pregnancy.
    Sorosky JI; Ingardia CJ; Botti JJ
    Am J Perinatol; 1989 Jan; 6(1):46-8. PubMed ID: 2910318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The severity of sevoflurane-induced malignant hyperthermia.
    Migita T; Mukaida K; Kobayashi M; Hamada H; Kawamoto M
    Acta Anaesthesiol Scand; 2012 Mar; 56(3):351-6. PubMed ID: 22092278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dantrolene in the treatment of life-threatening psychiatric disease pictures. A contribution to the therapy of the malignant neuroleptic syndrome and acute febrile catatonia].
    Schulte-Sasse U; Komar K; Eberlein HJ
    Dtsch Med Wochenschr; 1985 Mar; 110(12):457-61. PubMed ID: 3979279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Malignant hyperthermia--still a current and dangerous problem].
    Løvstad RZ; Halvorsen P; Steen PA; Lindal S
    Tidsskr Nor Laegeforen; 1995 May; 115(12):1494-8. PubMed ID: 7770853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A screening test for the malignant hyperpyrexia phenotype using suxamethonium-induced contracture of muscle treated with caffeine and its inhibition by dantrolene.
    Halsall PJ; Ellis FR
    Br J Anaesth; 1979 Aug; 51(8):753-6. PubMed ID: 497072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dantrolene sodium in the treatment of malignant hyperthermia. A case report.
    Harrison GG
    S Afr Med J; 1981 Dec; 60(23):909-10. PubMed ID: 7302773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Malignant hyperthermia--a hereditary and potentially life-threatening condition].
    Haugen T; Toft M; Müller CR; Aasly J
    Tidsskr Nor Laegeforen; 2005 Oct; 125(20):2792-4. PubMed ID: 16244682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines.
    Glahn KPE; Bendixen D; Girard T; Hopkins PM; Johannsen S; Rüffert H; Snoeck MM; Urwyler A;
    Br J Anaesth; 2020 Aug; 125(2):133-140. PubMed ID: 32591088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant hyperthermia and the conscious patient.
    Kemp DR; Choong LS
    Aust N Z J Surg; 1988 May; 58(5):423-7. PubMed ID: 3178598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dantrolene sodium and management of malignant hyperthermia.
    Fuerst DL; Toth AJ
    AANA J; 1983 Aug; 51(4):406-10. PubMed ID: 6556878
    [No Abstract]   [Full Text] [Related]  

  • 33. Malignant hyperthermia in Duchenne muscular dystrophy.
    Brownell AK; Paasuke RT; Elash A; Fowlow SB; Seagram CG; Diewold RJ; Friesen C
    Anesthesiology; 1983 Feb; 58(2):180-2. PubMed ID: 6824172
    [No Abstract]   [Full Text] [Related]  

  • 34. Dantrolene for malignant hyperthermia during anesthesia.
    Med Lett Drugs Ther; 1980 Jul; 22(15):61-2. PubMed ID: 7393124
    [No Abstract]   [Full Text] [Related]  

  • 35. [A case of malignant hyperthermia without hyperthermia].
    Muiños PA; Ortells MA; Sánchez G; Carrasco MS
    Rev Esp Anestesiol Reanim; 1995 Dec; 42(10):436. PubMed ID: 8789530
    [No Abstract]   [Full Text] [Related]  

  • 36. Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy.
    Carr AS; Lerman J; Cunliffe M; McLeod ME; Britt BA
    Can J Anaesth; 1995 Apr; 42(4):281-6. PubMed ID: 7788824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant hyperpyrexia and isoflurane. A case report.
    Thomas DW; Dev VJ; Whitehead MJ
    Br J Anaesth; 1987 Sep; 59(9):1196-8. PubMed ID: 3663443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Malignant hyperthermia].
    Glahn KP
    Ugeskr Laeger; 2003 Apr; 165(17):1763-8. PubMed ID: 12768904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of otolaryngic patients susceptible to malignant hyperthermia without dantrolene.
    Derkay CS; Grundfast KM
    Otolaryngol Head Neck Surg; 1991 Nov; 105(5):680-6. PubMed ID: 1754251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An autopsy case of malignant hyperthermia.
    Kimura H; Yoshida K; Ohsawa M; Arai T; Tsujimura T
    Forensic Sci Int; 1985 Jan; 27(1):25-30. PubMed ID: 3988193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.